Performance of CERE Cerevel Therapeutics Ho.. | 33.3% in 12m
Compare CERE with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Cerevel Therapeutics Ho.. with its related Sector/Index XBI
Performance Duell CERE vs XBI
| TimeFrame | CERE | XBI |
|---|---|---|
| 1 Day | -0.09% | 1.86% |
| 1 Week | 0.19% | 7.77% |
| 1 Month | 0.52% | -1.16% |
| 3 Months | 1.67% | 2.28% |
| 6 Months | 61.4% | 25.94% |
| 12 Months | 33.3% | 8.16% |
| YTD | 0.81% | -0.28% |
| Rel. Perf. 1m | 0.31 | |
| Rel. Perf. 3m | -0.06 | |
| Rel. Perf. 6m | 2.74 | |
| Rel. Perf. 12m | 2.38 |
Is Cerevel Therapeutics Ho.. a good stock to buy?
No, based on ValueRay Fundamental Analyses, Cerevel Therapeutics Ho.. (NASDAQ:CERE) is currently (May 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -94.33 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CERE as of May 2024 is 42.79. This means that CERE is currently overvalued and has a potential downside of 0.56% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CERE as of May 2024 is 42.79. This means that CERE is currently overvalued and has a potential downside of 0.56% (Sold with Premium).
Is CERE a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 9
- Sell: 0
- Strong Sell: 0
Values above 0%: CERE is performing better - Values below 0%: CERE is underperforming
Compare CERE with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.41% | 2.08% | 42.95% | 6.18% |
| US NASDAQ 100 | QQQ | -0.85% | 2.02% | 42.53% | -4.87% |
| US Dow Jones Industrial 30 | DIA | -0.98% | 1.62% | 46.80% | 15.30% |
| German DAX 40 | DBXD | 1.08% | 2.59% | 43.15% | 20.15% |
| UK FTSE 100 | ISFU | -1.47% | -2.69% | 47.05% | 23.85% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -3.32% | -3.11% | 58.21% | 43.08% |
| Hongkong Hang Seng | HSI | -5.57% | -7.54% | 62.62% | 47.17% |
| Japan Nikkei 225 | EXX7 | -2.16% | 5.33% | 47.80% | 12.89% |
| India NIFTY 50 | INDA | -0.59% | -1.51% | 41.99% | 4.19% |
| Brasil Bovespa | EWZ | -2.25% | -0.17% | 56.54% | 9.04% |
CERE Cerevel Therapeutics Ho.. vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.07% | 3.66% | 42.08% | -4.97% |
| Consumer Discretionary | XLY | -0.95% | 1.66% | 49.94% | 9.98% |
| Consumer Staples | XLP | -0.19% | -1.29% | 49.39% | 31.42% |
| Energy | XLE | 3.50% | 5.19% | 52.73% | 12.05% |
| Financial | XLF | 0.85% | 3.16% | 40.33% | 4.16% |
| Health Care | XLV | -0.43% | 2.74% | 49.99% | 26.04% |
| Industrial | XLI | 0.10% | 2.34% | 39.55% | 7.35% |
| Materials | XLB | 0.18% | 4.13% | 46.58% | 17.42% |
| Real Estate | XLRE | -1.35% | 4.19% | 54.13% | 28.34% |
| Technology | XLK | -1.17% | 2.85% | 43.04% | -4.44% |
| Utilities | XLU | -3.16% | -4.56% | 48.87% | 29.34% |
| Aerospace & Defense | XAR | -2.29% | -1.13% | 45.85% | 9.84% |
| Biotech | XBI | -7.58% | 1.68% | 35.48% | 25.14% |
| Homebuilder | XHB | -1.26% | 3.66% | 25.08% | -16.71% |
| Retail | XRT | -0.08% | 3.24% | 42.37% | 9.84% |
Does Cerevel Therapeutics Ho.. outperform its market, is CERE a Sector Leader?
Yes, over the last 12 months Cerevel Therapeutics Ho.. (CERE) made 33.30%, while its related Sector, the SPDR S&P Biotech (XBI) made 8.16%.
Over the last 3 months CERE made 1.67%, while XBI made 2.28%.
Yes, over the last 12 months Cerevel Therapeutics Ho.. (CERE) made 33.30%, while its related Sector, the SPDR S&P Biotech (XBI) made 8.16%.
Over the last 3 months CERE made 1.67%, while XBI made 2.28%.
| Period | CERE | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 0.52% | -1.16% | -1.56% |
| 3 Months | 1.67% | 2.28% | 3.75% |
| 12 Months | 33.30% | 8.16% | 27.12% |